Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Sunday, November 10, 2019, 7:13
- PR Newswire
- Add a comment
SAN FRANCISCO, Nov. 9, 2019 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced the presentation of five clinical and preclinical data abstracts focused on its immuno-oncology portfolio at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting. New clinical…
About the Author
admin has written 20655 stories on this site.